|
Originally published In Press as doi:10.1074/jbc.M207556200 on September 10, 2002
J. Biol. Chem., Vol. 277, Issue 48, 46304-46309, November 29, 2002
Subcloning, Expression, Purification, and Characterization of
Recombinant Human Leptin-binding Domain*
Yael
Sandowski §,
Nina
Raver§¶,
Eugene E.
Gussakovsky ,
Suzan
Shochat**,
Orly
Dym**,
Oded
Livnah**,
Menachem
Rubinstein ,
Radha
Krishna , and
Arieh
Gertler¶§§
From the ¶ Institute of Biochemistry, Food Science and
Nutrition, Faculty of Agricultural, Food and Environmental Quality
Sciences, The Hebrew University, Rehovot 76100, Israel,
Department of Life Sciences, Bar Ilan University, Ramat Gan
52900, Israel and Institute of Horticulture, The Volcani Center, ARO,
Bet Dagan 50250, Israel, ** The Institute of Life
Sciences, Faculty of Life Sciences, The Hebrew University of
Jerusalem, Jerusalem 91904, Israel,
 Department of Molecular Genetics, Weizmann
Institute of Science, Rehovot 76100, Israel and
Diagnostic System Laboratories, Webster, Texas 77598
A subdomain of the human leptin receptor encoding
part of the extracellular domain (amino acids 428 to 635) was
subcloned, expressed in a prokaryotic host, and purified to
homogeneity, as evidenced by SDS-PAGE, with over 95% monomeric
protein. The purified leptin-binding domain (LBD) exhibited the
predicted structure, was capable of binding human, ovine, and
chicken leptins, and formed a stable 1:1 complex with all mammalian
leptins. The binding kinetics, assayed by surface plasmon resonance
methodology, showed respective kon and
koff values (mean ± S.E.) of 1.20 ± 0.23 × 10 5 mol 1 s 1 and
1.85 ± 0.30 × 10 3 s 1 and a
Kd value of 1.54 × 10 8
M. Similar results were achieved with conventional binding
experiments. LBD blocked leptin-induced, but not interleukin-3-induced,
proliferation of BAF/3 cells stably transfected with the long form of
human leptin receptor. The modeled LBD structure and the known
three-dimensional structure of human leptin were used to construct a
model of 1:1 LBD·human leptin complex. Two main residues, Phe-500,
located in loop L3, and Tyr-441, located in L1, are suggested to
contribute to leptin binding.
*
This work was supported by Israeli Science Foundation
Research Grant 594/02 (to A. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Contributed equally to this work.
§§
To whom correspondence should be addressed. Tel.: 972-89-489-006;
Fax: 972-89-476-189; E-mail: gertler@agri.huji.ac.il.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. P. Richards and M. Proszkowiec-Weglarz
Mechanisms Regulating Feed Intake, Energy Expenditure, and Body Weight in Poultry
Poult. Sci.,
July 1, 2007;
86(7):
1478 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Peelman, H. Iserentant, A.-S. De Smet, J. Vandekerckhove, L. Zabeau, and J. Tavernier
Mapping of Binding Site III in the Leptin Receptor and Modeling of a Hexameric Leptin{middle dot}Leptin Receptor Complex
J. Biol. Chem.,
June 2, 2006;
281(22):
15496 - 15504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Leiter and C.-H. Lee
Mouse Models and the Genetics of Diabetes: Is There Evidence for Genetic Overlap Between Type 1 and Type 2 Diabetes?
Diabetes,
December 1, 2005;
54(suppl_2):
S151 - S158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zabeau, D. Defeau, H. Iserentant, J. Vandekerckhove, F. Peelman, and J. Tavernier
Leptin Receptor Activation Depends on Critical Cysteine Residues in Its Fibronectin Type III Subdomains
J. Biol. Chem.,
June 17, 2005;
280(24):
22632 - 22640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Iserentant, F. Peelman, D. Defeau, J. Vandekerckhove, L. Zabeau, and J. Tavernier
Mapping of the interface between leptin and the leptin receptor CRH2 domain
J. Cell Sci.,
June 1, 2005;
118(11):
2519 - 2527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, and J. Tavernier
Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist
J. Biol. Chem.,
September 24, 2004;
279(39):
41038 - 41046.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|